Compare AQST & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AQST | VMD |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.4M | 465.4M |
| IPO Year | 2007 | 2018 |
| Metric | AQST | VMD |
|---|---|---|
| Price | $3.70 | $11.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 271.6K |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.14 |
| EPS | N/A | ★ 0.06 |
| Revenue | $67,430,000.00 | ★ $270,280,000.00 |
| Revenue This Year | $10.08 | $17.88 |
| Revenue Next Year | $49.60 | $14.98 |
| P/E Ratio | ★ N/A | $195.75 |
| Revenue Growth | 0.77 | ★ 20.52 |
| 52 Week Low | $2.94 | $5.96 |
| 52 Week High | $7.55 | $12.61 |
| Indicator | AQST | VMD |
|---|---|---|
| Relative Strength Index (RSI) | 37.30 | 44.83 |
| Support Level | $3.16 | $9.26 |
| Resistance Level | $4.35 | $12.61 |
| Average True Range (ATR) | 0.20 | 0.35 |
| MACD | -0.03 | -0.13 |
| Stochastic Oscillator | 18.55 | 1.50 |
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.